Candriam S.C.A. Biolife Solutions Inc Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$27.5 - $45.75 $1.24 Million - $2.06 Million	-45,000 Closed	0 $0
Q3 2020 Oct 19, 2020	SELL	$16.04 - $28.94 $497,240 - $897,140	-31,000 Reduced 40.79%	45,000 $1.3 Million
Q3 2018 Nov 07, 2018	BUY	$14.99 - $25.48 $1.14 Million - $1.94 Million	76,000 New	76,000 $1.33 Million

198

45.3M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $924M
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.